Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 796

Cruise crushes $1.15bn fundraise

GM's autonomous driving spinoff, Cruise Automation, has received $1.15bn from investors including SoftBank Vision Fund and Honda as well as its parent company.

May 8, 2019

SamanTree branches out with $9.3m

Sioux Technologies co-led SamanTree’s series A round, which will support marketing of the EPFL spinout’s subcellular resolution microscopy scanner for surgical cancer interventions.

May 8, 2019

Rfrnz reaches seven-digit understanding

TUM automated legal analysis spinout Rfrnz has secured backing from Unternehmertum-operated Initiative for Industrial Innovations, HTGF and unnamed additional investors.

May 8, 2019

Dynabind dines on seed financing

TU Dresden-founded drug discovery platform operator Dynabind has advanced research from the lab of Yixin Zhang in the university’s B Cube Center for Molecular Bioengineering.

May 8, 2019

Byton moves closer to $500m series C

FAW Group will reportedly provide $100m for Byton for a $500m round likely to value the electric SUV developer at more than $2.5bn.

May 8, 2019

Gett gains $200m at $1.5bn valuation

All Gett’s existing investors, including Volkswagen and Access Industries, have participated in a $120m extension that brought its latest round to $200m.

May 8, 2019

SoftBank helps Clip collect $100m

SoftBank tapped its Innovation Fund to invest about $20m in the card reader developer as part of a $100m round that valued it at up to $400m.

May 8, 2019

Noom finds room for $58m

Existing backer Samsung Ventures contributed to a round that boosted the health maintenance platform developer's overall funding to more than $86m.

May 8, 2019

Ola Electric Mobility extends series A round

Ola's electric vehicle-focused spinoff has added an undisclosed amount to the $56m in series A funding the company received in March.

May 8, 2019

Confo confirms $33.4m

The funding, provided by investors including Qbic, will allow VUB and VIB spinout Confo Therapeutics to accelerate its drug discovery efforts and move towards clinical trials.

May 8, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here